Oncology
Rheumatology
Neurology
Other Products
Eltrombopag
Eltrombopag is indicated for the treatment of immune thrombocytopenia (ITP), thrombocytopenia associated with chronic hepatitis C virus (HCV) infection, and severe aplastic anemia (SAA).